This approach has succeeded on the basis of the asparaginase template whereby asparagine deprivation for acute lymphoblastic leukaemia is deployed in the context of multimodality therapy rather than as monotherapy. The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.